NIDA does not fund or assist in the collection of these data but does analyze NCHS data to create the figures and descriptions on this page. If you or someone you love is struggling with Halfway house addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp. Oxycodone treats pain because it’s a central nervous system (CNS) depressant, meaning it reduces activity in the part of the brain and spinal cord related to pain.

Opioid-related deaths

Medical literature suggests a strong biologic plausibility between opioid analgesics and OIH and allodynia. If a patient is suspected to be experiencing OIH, carefully consider appropriately decreasing the dose of the current opioid analgesic or opioid rotation (safely switching the patient to a different opioid moiety). Overestimating the OXYCONTIN dosage when converting patients from another opioid product can result in a fatal overdose with the first dose.

Find Treatment

If you do not have a take-back program nearby or one that you can access promptly, flush any oxycodone medication down the toilet so that others will not take it.Talk to your pharmacist about the proper disposal of your medication. Overdose prevention is a CDC priority that impacts families and communities. Accidental ingestion of even one dose of OXYCONTIN, especially by children, can result in a fatal overdose of oxycodone. Alcohol and drug dependant people are being sought to take part in brain trials to stop addiction. Nitazenes were detected in 38 drug deaths in Scotland between January and March 2025. If you feel that the medicine is not working as well, do not use more than your prescribed dose.

The background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, how addictive is oxycontin or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively.

Moderate-to-Severe Pain

For patients with hepatic impairment, start dosing patients at one-third to one-half the recommended starting dosage and titrate the dosage carefully. Regularly evaluate for signs of respiratory depression, sedation, and hypotension see Use In Specific Populations and CLINICAL PHARMACOLOGY. The presence of risk factors for overdose should not prevent the proper management of pain in any given patient see WARNINGS AND PRECAUTIONS. Discuss the availability of naloxone for the emergency treatment of opioid overdose with the patient and caregiver and assess the potential need for access to naloxone, both when initiating and renewing treatment with OXYCONTIN see WARNINGS AND PRECAUTIONS. Do not drink alcohol or use prescription or over-the-counter medicines that contain alcohol while taking oxycodone.

Inform patients that anaphylaxis has been reported with ingredients contained in OXYCONTIN. Advise patients how to recognize such a reaction and when to seek medical attention see CONTRAINDICATIONS and ADVERSE REACTIONS. Tolerance is a physiological state characterized by a reduced response to a drug https://ebdinsaatmakina.com.tr/how-to-follow-step-9-in-aa-making-amends/ after repeated administration (i.e., a higher dose of a drug is required to produce the same effect that was once obtained at a lower dose). Both tolerance and physical dependence can develop during use of opioid therapy. Additional data, including epidemiological data, when available, may provide further information on the impact of the current formulation of OXYCONTIN on the abuse liability of the drug.

• When subjected to an aqueous environment, OXYCONTIN gradually forms a viscous hydrogel (i.e., a gelatinous mass) that resists passage through a needle.
• Tell your doctor right away if you think you are pregnant or if you plan to become pregnant while using this medicine.
• This condition differs from tolerance, which is the need for increasing doses of opioids to maintain a defined effect see Dependence.
• Advise patients and caregivers that when medicines are no longer needed, they should be disposed of promptly.
• Choropleth maps of the US states were created for each year from 2000 to 2021 for MME per person, total opioid deaths and each of the five subcategories contributing to total opioid deaths (online supplemental file 2 – maps 1–7).
• If you have a feeding tube, the extended-release capsule contents can be poured into the tube.

This medicine is available only under a restricted distribution program called the Opioid Analgesic REMS (Risk Evaluation and Mitigation Strategy) program. You shouldn’t take immediate-release oxycodone or OxyContin if you have asthma, other breathing problems, kidney disease, or liver disease. Immediate-release oxycodone and OxyContin can make these conditions worse. While this pathway may be blocked by a variety of drugs such as certain cardiovascular drugs (e.g., quinidine) and antidepressants (e.g., fluoxetine), such blockade has not been shown to be of clinical significance with OXYCONTIN see DRUG INTERACTIONS. In the pediatric age group of 11 years of age and older, systemic exposure of oxycodone is expected to be similar to adults at any given dose of OXYCONTIN. Oxycodone is extensively metabolized by multiple metabolic pathways to produce noroxycodone, oxymorphone and noroxymorphone, which are subsequently glucuronidated.

• Instruct patients to swallow OXYCONTIN tablets whole; crushing, chewing, or dissolving OXYCONTIN tablets can cause rapid release and absorption of a potentially fatal dose of oxycodone see WARNINGS AND PRECAUTIONS.
• Do not take oxycodone unless it has been prescribed to you by a health care provider.
• The MME for 10 opioids including oxycodone in 2016 in North Dakota was almost half (485) of this.22 These pronounced and persistent state-level disparities may offer opportunities for continued vigilance in opioid stewardship.
• Call your doctor right away if you have worsening of pain, increased sensitivity to pain, or new pain after taking this medicine.

Drug Overdose Death Rates

Overall, the effects of opioids appear to be modestly immunosuppressive. In case of overdose, priorities are the reestablishment of a patent and protected airway and institution of assisted or controlled ventilation, if needed. Employ other supportive measures (including oxygen, vasopressors) in the management of circulatory shock and pulmonary edema as indicated. Cardiac arrest or arrhythmias will require advanced life support measures. The most frequent adverse events observed in pediatric patients were vomiting, nausea, headache, pyrexia, and constipation see DOSAGE AND ADMINISTRATION, ADVERSE REACTIONS, CLINICAL PHARMACOLOGY and Clinical Studies. The safety and efficacy of OXYCONTIN have been established in pediatric patients ages 11 to 16 years.

CDC is committed to addressing the opioid overdose epidemic and supporting states and communities as they continue work to identify outbreaks, collect data, respond to overdoses, and provide care to those in their communities. Using this medicine while you are pregnant may cause serious unwanted effects, including neonatal withdrawal syndrome in your newborn baby. Tell your doctor right away if you think you are pregnant or if you plan to become pregnant while using this medicine. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

What is the dosage for Oxycontin?

Collaboration is essential for success in preventing opioid overdose deaths. Together, we can better coordinate efforts to prevent opioid overdoses and deaths. Hepatic Impairment A study of OXYCONTIN in patients with hepatic impairment demonstrated greater plasma concentrations than those seen at equivalent doses in persons with normal hepatic function. Regularly evaluate closely for signs of respiratory depression, sedation, and hypotension. After stopping a CYP3A4 inhibitor, as the effects of the inhibitor decline, the oxycodone plasma concentration will decrease, resulting in decreased opioid efficacy or a withdrawal syndrome in patients who had developed physical dependence to oxycodone.